Palvella Therapeutics, Inc. PVLA

Set alert

175.92 USD +19.07 (+12.16%)

At closeNov 6, 2026, 4:00 PM EST

175.92 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

156.54 Day range 176.60

72.23 52-week range 176.60

Held by insiders 11.21%

Held by institutions 105.04%

Float held by institutions 118.31%

Institutions 280

Top institutional holders
Holder	% held	Shares	Value	Reported
Montanova Capital LLC	7.88%	1,135,406	199.74M	Jun 29, 2026
Jennison Associates LLC	6.67%	960,619	168.99M	Jun 29, 2026
Blackrock Inc.	6.37%	918,357	161.56M	Jun 29, 2026
Frazier Life Sciences Management, L.P.	6.12%	882,400	155.23M	Jun 29, 2026
First Light Asset Management, LLC	5.36%	771,901	135.79M	Jun 29, 2026
BVF Inc.	4.67%	672,789	118.36M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.70%	388,390	68.33M	Jun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	2.51%	362,314	63.74M	Sep 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.14%	308,699	54.31M	Sep 29, 2026
Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund	1.92%	276,556	48.65M	Jul 30, 2026
MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund	1.61%	231,484	40.72M	Jun 29, 2026
PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund	1.47%	212,225	37.33M	Sep 29, 2026

PVLA insiders
Insider	Relation	Latest transaction	Date	Shares held
GOIN KATHLEEN	Chief Operating Officer	Sale	Aug 18, 2026	0
HERON ELAINE J	Director	Purchase	Feb 26, 2026	53,691
JENKINS GEORGE M	Director	Sale	Oct 13, 2026	146,132
KIRITSY CHRISTOPHER P	Director	Sale	Sep 1, 2026	250
KORENBERG MATTHEW E	Chief Financial Officer	Conversion of Exercise of derivative security	Jun 11, 2026	1,000

Held by funds